Investing in ways to address social risk factors and health disparities related to treatments for burdensome conditions has become a critical component of advancing health equity in the US healthcare system. The foundation of understanding these treatment outcome inequities and of closing healthcare gaps is real-world evidence (RWE) generation and health economics and outcomes research (HEOR). This webinar will focus on how integrating social determinants of health (SDOH) data with claims-based research can provide an opportunity to improve treatment access and outcomes for under-represented populations through targeted research and strategic efforts.
Presenters:
- Christie Teigland, PhD, Vice President, Research Science and Advanced Analytics, Inovalon, Bowie, MD, USA
- Alexandra Ehrlich, MPH, Senior Director, Sales Engineering, Inovalon, Bowie, MD, USA
- Allison Petrilla, MPH, Vice President, HEOR, Inovalon, Bowie, MD, USA
Related Content
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields. This session focuses on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.
Beyond Accelerated Approvals: External Control Arms
Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.